GROVES REGINA E

USNatural personDirector

Insider

GROVES REGINA E

USNatural personDirector2 companies · 24mo

Transactions

Issuers

Buys / Sells

10/4

Last tx

18 May 2026

Behaviour

3 purchases reported after at least 12 months of silence — most recent on 30 Apr 2021.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
REVA Medical, Inc.	245,924.2	reported	29 Jun 2018	tx 15+2,705,924.2
AtriCure, Inc.	39,859	reported	18 May 2026	tx 18+55,988−16,129
Fulgent Genetics, Inc.	28,099	reported	14 May 2026	tx 7+50,339

Recent transactions

Date	Type	Issuer	Qty	Price
18 May 2026	GRANT_AWARD	AtriCure, Inc.	6,144	0.00 USD
14 May 2026	GRANT_AWARD	Fulgent Genetics, Inc.	11,117	0.00 USD
06 Aug 2025	SALE	AtriCure, Inc.	2,452	36.82 USD
19 May 2025	GRANT_AWARD	AtriCure, Inc.	5,401	0.00 USD
15 May 2025	GRANT_AWARD	Fulgent Genetics, Inc.	8,982	0.00 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
REVA Medical, Inc.	245,924.2	reported	29 Jun 2018	tx 15+2,705,924.2
AtriCure, Inc.	39,859	reported	18 May 2026	tx 18+55,988−16,129
Fulgent Genetics, Inc.	28,099	reported	14 May 2026	tx 7+50,339

Recent transactions

Date	Type	Issuer	Qty	Price
18 May 2026	GRANT_AWARD	AtriCure, Inc.	6,144	0.00 USD
14 May 2026	GRANT_AWARD	Fulgent Genetics, Inc.	11,117	0.00 USD
06 Aug 2025	SALE	AtriCure, Inc.	2,452	36.82 USD
19 May 2025	GRANT_AWARD	AtriCure, Inc.	5,401	0.00 USD
15 May 2025	GRANT_AWARD	Fulgent Genetics, Inc.	8,982	0.00 USD